Vasilios J. Assikis, MD | Authors

Risks and Benefits of Tamoxifen Therapy

February 01, 1997

Tamoxifen is the most widely prescribed endocrine therapy for breast cancer, with more than 7.5 million woman-years of clinical experience. Tamoxifen has both antiestrogenic and estrogenic activity. The antiestrogenic activity